For more than 60 years, the pharmaceutical company ELPEN has been developing and producing high quality branded and generic medicines for the Greek and International markets.
Led by a visionary pharmacist, Dimitris Pentafragas, a small team of scientists laid the foundations of ELPEN.
Construction of the manufacturing plant in Pikermi begins.
Development of generics & manufacturing on behalf of third party pharmaceutical companies.
Launch and consolidation of ELPEN's export activity.
The Research & Experimental Center of ELPEN is founded. This is the first private fully developed Research & Development site in Greece.
Invention of the original and patented ELPENHALER® dry powder inhaler, protected by ELPEN’s international patents. The device is used for the administration of multiple single doses of medicines for respiratory diseases.
The subsidiary ELPEN PHARMA GmbH is founded in Berlin, Germany, offering high-quality pharmaceutical products in various therapeutic categories.
Launched in 40 countries. Statin combination pharmaceuticals. Introduction to markets across Europe.
We lay the foundation for the: • Expansion of R&D and modernization of the manufacturing facilities in Pikermi • Design of the Biotechnology Park - Athens LifeTech Park in Spata • Configuration of the NEW manufacturing plant in Keratea
Start of operations at Plant I, featuring two manufacturing units.
The subsidiary ELPEN Middle East Africa is founded in Dubai, United Arab Emirates.
2026 - 2027